Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.20)
# 2,594
Out of 4,829 analysts
290
Total ratings
57.04%
Success rate
-1.02%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare | Maintains: Overweight | $165 → $175 | $148.83 | +17.58% | 2 | May 5, 2025 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $60 → $40 | $51.96 | -23.02% | 3 | Apr 29, 2025 | |
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $181.78 | +10.02% | 1 | Mar 26, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $195 → $201 | $237.05 | -15.21% | 7 | Mar 6, 2025 | |
| ARDT Ardent Health Partners | Maintains: Overweight | $24 → $22 | $14.52 | +51.52% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $6.84 | +53.51% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.32 | +38.89% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $353.70 | +0.37% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $117.05 | -17.13% | 14 | Nov 5, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $3.69 | +35.50% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $68.21 | +67.13% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $25.55 | +123.09% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $55.33 | +46.39% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $59.19 | -40.87% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.11 | +5.20% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $73.20 | +152.73% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $152.88 | +9.24% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $80.88 | -48.07% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $176.96 | -10.15% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $66.97 | +86.65% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $208.20 | -65.27% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $172.27 | +13.19% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $380.64 | +28.21% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $322.20 | -8.13% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $245.73 | +49.76% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $249.53 | +105.59% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $333.46 | -17.53% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $62.79 | +40.15% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $40.98 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $59.83 | +209.21% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $191.88 | +11.01% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $100.00 | -42.00% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $207.51 | -43.62% | 15 | Jun 16, 2020 |
Tenet Healthcare
May 5, 2025
Maintains: Overweight
Price Target: $165 → $175
Current: $148.83
Upside: +17.58%
Hims & Hers Health
Apr 29, 2025
Maintains: Equal-Weight
Price Target: $60 → $40
Current: $51.96
Upside: -23.02%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $181.78
Upside: +10.02%
Veeva Systems
Mar 6, 2025
Maintains: Underweight
Price Target: $195 → $201
Current: $237.05
Upside: -15.21%
Ardent Health Partners
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $14.52
Upside: +51.52%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $6.84
Upside: +53.51%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.32
Upside: +38.89%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $353.70
Upside: +0.37%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $117.05
Upside: -17.13%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.69
Upside: +35.50%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $68.21
Upside: +67.13%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $25.55
Upside: +123.09%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $55.33
Upside: +46.39%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $59.19
Upside: -40.87%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $17.11
Upside: +5.20%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $73.20
Upside: +152.73%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $152.88
Upside: +9.24%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $80.88
Upside: -48.07%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $176.96
Upside: -10.15%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $66.97
Upside: +86.65%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $208.20
Upside: -65.27%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $172.27
Upside: +13.19%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $380.64
Upside: +28.21%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $322.20
Upside: -8.13%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $245.73
Upside: +49.76%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $249.53
Upside: +105.59%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $333.46
Upside: -17.53%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $62.79
Upside: +40.15%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $40.98
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $59.83
Upside: +209.21%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $191.88
Upside: +11.01%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $100.00
Upside: -42.00%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $207.51
Upside: -43.62%